U.S. markets ended Thursday with mixed performance: the Dow Jones Industrial Average climbed 0.4% to 43,239.05, the S&P 500 held steady at 5,841.47, and the Nasdaq inched up by 0.04% to close at ...

The study, published in ACS Nano, analysed 156 blood samples from 19 individuals over 28 days after receiving a Moderna ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

Moderna is facing allegations that it misused innovations from researchers at Northwestern University to develop its mRNA COVID-19 vaccines, which became widely available to the public in 2021 to ...

Combined company will operate as TuHURA Biosciences, Inc. and advance pipeline of novel technologies to overcome resistance to cancer immunotherapyLead program entering single Phase 3 accelerated appr ...

Before the fungal meningitis outbreak last year related to cosmetic surgery in Mexico, “I hadn’t fully appreciated the vast ...

Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...

As  the pharma sector grapples with legal and regulatory upheaval, LSPN Fall North America explored the need for companies to ...

Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...

The international authority on hunger crises says the Gaza Strip is still at risk of famine more than a year into the ...

Shares of American pharmaceutical company Novavax (NVAX) fell 19% on reports that the U.S. Food and Drug Administration (FDA) ...